leisure time -WSS

leisure time

author：focus 2025-09-29 16:34:37 - browse：3186

A medical device to treat below-the-knee chronic limb-threatening ischemia, Esprit BTK resorbable scaffold, is shown consisted of pieces of geometric shapes that lined up into a pipe on a blue background — health tech coverage from STAT — Cardiovascular doctors are optimistic about Abbott’s new below-knee stent that disappears into the blood vessel’s walls over the course of three years. Courtesy Abbott

An Abbott device that failed in heart disease patients is getting a new life in patients with severe vascular disease.

The device is a below-knee stent that widens clogged blood vessels, and then vanishes into the vessel’s walls over the course of three years. It also delivers a drug that prevents scar tissue from forming — a common risk factor with traditional metal stents that further narrow the vessel.

Abbott’s first dissolvable stent, for coronary artery disease, received Food and Drug Administration approval in 2016. But the company voluntarily pulled the product from the market just over a year later due to “low commercial uptake.” The device also received mixed results in clinical trials.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Sana to lay off nearly a third of staff, de

WSS

How to make AI work for medicine

Psilocybin's anti

How a symptom of dementia informs our understanding of creativity

CDC advisory panel says seniors 'may' get RSV vaccine

The future of health care in the House

FDA panel gives mixed vote on blood pressure devices

entertainment

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Wikipedia

Wildfire smoke exposes gaps in outdoor worker protections

A virus, fished out of a lake, may have saved a man’s life

George Santos makes 1st court appearance after pleading not guilty to 13 counts

What do new weight loss drugs mean for bariatric surgery?

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Psilocybin's anti

Medical leaders decry Supreme Court decision on affirmative action

AI can decode, harness the power of the humane immune system

State Dept. review finds Biden bears some blame for Afghanistan failures

Drug firms test therapies to halt Alzheimer’s before symptoms arise

Wikipedia

Apellis safety probe of eye disease drug centers on injection needle

AstraZeneca bets AAV gene therapy will still deliver the goods

Drug firms test therapies to halt Alzheimer’s before symptoms arise

Analysis of telehealth claims data suggest service duplication

Liquid biopsy for lung cancer is launched by Delfi

Phenylephrine and the overlooked value of the placebo effect

knowledge

Wikipedia

entertainment

hotspot